Professor of Stroke Medicine
- Chief Executive Officer, Oxford Academic Health Science Network
- Consultant Stroke Physician OUH
My work focuses on developing and evaluating treatments that can reduce brain damage in the first few hours after stroke, and developing better processes of care to deliver for stroke patients.
I have developed and evaluated the performance of stroke recognition instruments such as the Face Arm Speech Test (FAST) and Recognition of Stroke in the Emergency Room Scale (ROSIER) to improve early diagnosis of stroke by the public, ambulance paramedics and Emergency Department teams.
My work has evaluated the risks and benefits of thrombolysis in very elderly stroke patients 80 years or older, who are the population at highest risk of stroke.
In addition to my research in stroke my work more broadly seeks to understand the risks and benefits of drug therapies in older people.
Association of Time From Stroke Onset to Groin Puncture With Quality of Reperfusion After Mechanical Thrombectomy: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials.
Bourcier R. et al, (2019), JAMA Neurol
Pioglitazone Therapy in Patients with Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial
Spence JD. et al, (2019), JAMA Neurology
One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: An analysis of the ICON1 study.
Batty J. et al, (2019), Int J Cardiol, 274, 45 - 51
Case costing of mechanical thrombectomy for acute ischaemic stroke in routine clinical setting: cost differences between mothership vs drip and ship
Balami JS. et al, (2018), INTERNATIONAL JOURNAL OF STROKE, 13, 45 - 46
A trial to evaluate an extended rehabilitation service for stroke patients (EXTRAS): economic evaluation
Bhattarai N. et al, (2018), INTERNATIONAL JOURNAL OF STROKE, 13, 55 - 55